Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Laura Breda, Roberto Gambari, Stefano Rivella
    e2009008
    2009-11-16
    1293
    PDF: 428
    HTML: 2886
  • PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL P53 EXPRESSION IN BONE MARROW BIOPSY IN HIGHER RISK MDS: A PILOT STUDY

    Alfredo Molteni, Emanuele Ravano, Marta Riva, Michele Nichelatti, Laura Bandiera, Lara Crucitti, Mauro Truini, Roberto Cairoli
    e2019015
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.015
    1871
    PDF: 986
    HTML: 328
  • DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE

    Ibrahim C. Haznedaroglu
    e2015014
    2015-12-02
    https://doi.org/10.4084/mjhid.2015.014
    277695
    PDF: 1811
    HTML: 3875
  • TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS

    Eleonora De Bellis, Luana Fianchi, Francesco Buccisano, Marianna Criscuolo, Luca Maurillo, Laura Cicconi, Mattia Brescini, Maria Ilaria Del Principe, Ambra Di Veroli, Adriano Venditti, Francesco Lo-Coco, Maria Teresa Voso
    e2017045
    2017-07-01
    https://doi.org/10.4084/mjhid.2017.045
    4386
    PDF: 1773
    HTML: 1111
  • DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia

    Buket Altinok Gunes, Yalda Hekmatshoar, Tulin Ozkan, Sureyya Bozkurt, O.Sena Aydos, Yahya Buyukasik, Elifcan Aladag, Asuman Sunguroglu
    e2023008
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.008
    1352
    PDF: 1240
    HTML: 461
  • NUCLEOTIDE SUBSTITUTIONS IN HEPATITIS B VIRUSES DERIVED FROM CHRONIC HBV PATIENTS

    Narjes Shokatpour, Maryam Vaezjalali, Graham R Foster, Shahnaz Sali
    e2019046
    2019-06-24
    https://doi.org/10.4084/mjhid.2019.046
    1204
    PDF: 698
    HTML: 204
  • SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis

    Roberta Zanotti, Massimiliano Bonifacio, Ilaria Tanasi, Donatella Schena, Giovanni Orsolini, Morena Tebaldi, Lara Crosera, Francesca Mastropaolo, Elisa Olivieri, Dr. Patrizia Bonadonna
    e2021068
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.068
    1578
    PDF: 1042
    HTML: 238
  • Molecular characteristics of hepatitis B virus in children of Huzhou area, China

    Fang Jin, Fuchu Qian, Dongli Li, Chenxin Yan, Weihua Zou
    e2022061
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.061
    523
    PDF: 432
    HTML: 217
  • SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM

    Zohreh Rahimi, Abbas Parsian
    e2011024
    2011-05-23
    https://doi.org/10.4084/mjhid.2011.024
    2279
    PDF: 904
    HTML: 2099
  • EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

    Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca
    e2024042
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.042
    4376
    PDF: 1723
    HTML: 1043
  • The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones

    Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, Tiziana Ottone, Mariadomenica Divona, Arianna Savi, Francesco Buccisano, Luca Maurillo, Corrado Tarella, William Arcese, Maria Teresa Voso
    e2022041
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.041
    1277
    PDF: 772
    HTML: 320
  • PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis

    Fiorina Giona
    e2021069
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.069
    1877
    HTML: 1479
    PDF: 1109
  • ACUTE PROMYELOCYTIC LEUKEMIA: AN EXPERIENCE ON 95 GREEK PATIENTS TREATED IN THE ALL-TRANS-RETINOIC ACID ERA

    Maria Pagoni, Maria Garofalaki, Fotios Panitsas, Kalliopi Manola, Katerina Psarra, Panagiotis Economopoulos
    e2011053
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.053
    2866
    PDF: 896
    HTML: 3585
  • ACUTE PROMYELOCYTIC LEUKEMIA (APL): COMPARISON BETWEEN CHILDREN AND ADULTS

    Anna Maria Testi, Francesco Lococo
    e2014032
    2014-04-15
    https://doi.org/10.4084/mjhid.2014.032
    2811
    PDF: 1678
    HTML: 2270
  • COEXISTENCE OF MULTIPLE GENE VARIANTS IN SOME PATIENTS WITH ERYTHROCYTOSES Multiple gene variants in erythrocytosis

    Andrea Benetti, Irene Bertozzi, PhD, MD, Giulio Ceolotto, Irene Cortella, Daniela Regazzo, Giacomo Biagetti, Elisabetta Cosi, Maria Luigia Randi, MD, Prof
    e2024021
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.021
    867
    PDF: 1245
    HTML: 136
  • CAUSES OF ADULT SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA

    Valerio De Stefano, Tommaso Za, Angela Ciminello, Laura Betti, Elena Rossi
    e2011063
    2011-12-19
    https://doi.org/10.4084/mjhid.2011.063
    2632
    PDF: 940
    HTML: 3640
  • NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria

    Jonathan Braue, Vagishwari Murugesan, Steven Holland, Nishit Patel, Eknath Naik, Jennifer Leiding, Abraham Tareq Yacoub, Carlos N Prieto-Granada, John Norman Greene
    e2015010
    2014-12-27
    https://doi.org/10.4084/mjhid.2015.010
    1737
    PDF: 1109
    HTML: 10704
    Untitled: 194
  • PROGNOSIS AND THERAPY WHEN ACUTE PROMYELOCYTIC LEUKEMIA AND OTHER “GOOD RISK” ACUTE MYELOID LEUKEMIAS OCCUR AS A THERAPY-RELATED MYELOID NEOPLASM

    Richard A. Larson, Michelle Le Beau
    e2011032
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.032
    2863
    PDF: 937
    HTML: 1881
  • FINE MAPPING OF GLUCOSE 6 PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY IN RURAL AREA OF SOUTH WEST ODISHA USING THE CLINICAL, HEMATOLOGICAL AND MOLECULAR APPROACH

    Ravindra Kumar, MPSS Singh, Soumendu Mahapatra, Sonam Chourasia, Malay Kumar Tripathi, John Oommen, Praveen Kumar Bharti, Rajasubramaniam Shanmugam
    e2020015
    2020-02-26
    https://doi.org/10.4084/mjhid.2020.015
    1773
    PDF: 1037
    HTML: 560
  • TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS

    Luca Maurillo, Francesco Buccisano, Maria Ilaria Del Principe, Chiara Sarlo, Luigi Di Caprio, Concetta Ditto, Federica Giannotti, Daniela Nasso, Eleonora Ceresoli, Massimiliano Postorino, Marco Refrigeri, Sergio Amadori, Adriano Venditti
    e2013032
    2013-06-03
    https://doi.org/10.4084/mjhid.2013.032
    2837
    PDF: 1018
    HTML: 5526
  • MOLECULAR HETEROGENEITY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY IN BURKINA FASO: G-6-PD BETICA SELMA AND SANTAMARIA IN PEOPLE WITH SYMPTOMATIC MALARIA IN OUAGADOUGOU

    Abdoul Karim OUATTARA, Pouiré YAMEOGO, Birama DIARRA, Dorcas OBIRI-YEBOAH, Albert Theophane YONLI, Tegwindé Rebeca COMPAORE, Serge Théophile SOUBEIGA, Florencia Wenkuuni DJIGMA, Jacques Simpore
    e2016029
    2016-06-15
    https://doi.org/10.4084/mjhid.2016.029
    4194
    PDF: 1030
    HTML: 1393
  • ON THE VERSATILITY OF VON WILLEBRAND FACTOR

    Antoine Rauch, Peter Lenting
    e2013046
    2013-07-10
    https://doi.org/10.4084/mjhid.2013.046
    2839
    PDF: 1132
    HTML: 11225
  • WALDENSTRÖM MACROGLOBULINEMIA - A STATE-OF-THE-ART REVIEW: PART 2- FOCUS ON THERAPY

    Michele Bibas, Shayna Sarosiek , Jorge Castillo
    e2025015
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.015
    2582
    PDF: 2034
    HTML: 221
  • BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN

    Maria Teresa Voso, Giulia Falconi, Dr. Fabiani
    e2023055
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.055
    1821
    PDF: 992
    HTML: 147
  • MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE IN EGYPTIAN CHILDREN

    Nermeen Galal, Jeannette Boutros, Aisha Marsafy, Xiao-Fei Kong, Jacqueline Feinberg, Jean-Laurent Casanova, Stéphanie Boisson-Dupuis, Jacinta Bustamante
    e2012033
    2012-05-07
    https://doi.org/10.4084/mjhid.2012.033
    1822
    PDF: 850
    HTML: 1153
    Cover: 184
  • IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

    Federica Sorà, Patrizia Chiusolo, Francesco autore, Sabrina Giammarco, luca laurenti, elisabetta metafuni, idanna innocenti, eugenio galli, andrea bacigalupo, simona sica
    e2021062
    2021-10-29
    https://doi.org/10.4084/MJHID.2021.062
    1248
    PDF: 475
    HTML: 164
  • HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS

    Mazyar Shadman, Joachim Deeg
    e2014056
    2014-09-01
    https://doi.org/10.4084/mjhid.2014.056
    2042
    PDF: 768
    HTML: 3117
  • PATHOBIOLOGY OF HODGKIN LYMPHOMA

    Claudio Agostinelli, Stefano Pileri
    e2014040
    2014-06-05
    https://doi.org/10.4084/mjhid.2014.040
    3264
    PDF: 1462
    HTML: 5953
    Fig1-Ag-Pil: 234
    Ag-Pil Fig.2: 237
  • JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia

    Phakatip Sinlapamongkolkul, Pacharapan Surapolchai, Vip Viprakasit
    e2023056
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.056
    2288
    PDF: 619
    Suppl. Files: 286
    HTML: 176
  • HbD Punjab/HbQ India compound heterozygosity: An unusual association.

    Stacy Colaco, Reema Surve, Pratibha Sawant, Anita Nadkarni, Kanjaksha Ghosh, Roshan Colah
    e2014072
    2014-11-01
    https://doi.org/10.4084/mjhid.2014.072
    1558
    PDF: 815
    HTML: 5586
  • EFFECT OF CIS ACTING POTENTIAL REGULATORS IN THE ß GLOBIN GENE CLUSTER ON THE PRODUCTION OF HBF IN THALASSEMIA PATIENTS

    Anita Nadkarni
    e2013012
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.012
    1140
    PDF: 605
    HTML: 3341
  • Formulas for the Detection ?-Thalassemia Carriers Are Affected by Changes in Red Cell Parameters

    Deniz Aslan
    e2018026
    2018-04-20
    https://doi.org/10.4084/mjhid.2018.026
    1375
    PDF: 675
    HTML: 320
  • NOVEL RUNX1 VARIATION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

    Egzona Qipa, Muradiye Acar, Sureyya Bozkurt, Murat Buyukdogan, Hazal Berivan Sonmez, Muge Sayitoglu, Yucel Erbilgin, Zeynep Karakas, Veysel Sabri Hancer
    e2023036
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.036
    881
    PDF: 732
    HTML: 269
  • Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era

    Serena Vita, Emanuela Giacobini, Patrizia De Marco, Martina Rueca, Cesare Ernesto Maria Gruber, Alessia Beccacece, Laura Scorzolini, Valentina Mazzotta, Carmen Pinnetti, Priscilla Caputi, Daniele Focosi, Enrico Girardi, Andrea Antinori, Fabrizio Maggi, Alessandra D'Abramo, Emanuele Nicastri, Spallanzani COVID-19 case Investigation Team
    e2024043
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.043
    1311
    PDF: 947
    HTML: 91
  • Clinical Characteristics and Treatment Response of a Novel ELANE Gene Mutation (c.295_303del) in Congenital Neutropenia

    Junjie Ning
    e2024024
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.024
    621
    PDF: 1102
    HTML: 174
  • Clinical spectrum and genotypes of children with alpha-thalassemia in northeastern, Thailand

    Patcharee Komvilaisak, Nattakarn Sangkha, Arunee Jetsrisuparp, Kunanya Suwannaying, Goonnapa Fucharoen, Napat Laoaroon
    e2025081
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.081
    311
    PDF: 222
    Html: 79
  • IMPACT OF MANNOSE-BINDING PROTEIN GENE POLYMORPHISMS IN OMANI SICKLE CELL DISEASE PATIENTS

    Mathew Zachariah, Anil Pathare
    e2016013
    2016-02-11
    https://doi.org/10.4084/mjhid.2016.013
    3205
    PDF: 766
    HTML: 1596
  • Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission

    Beatrice Borsellino, Arianna Savi, Maria Rosaria Pascale, Elisa Meddi, Antonio Cristiano, TIZIANA OTTONE, Maria Cristina Rapanotti, Mariadomenica Divona, SERENA TRAVAGLINI, Enrico Attardi, Elisa Buzzatti, Francesco Buccisano, Maria Teresa Voso
    e2022058
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.058
    1692
    PDF: 782
    HTML: 264
  • THE BROAD-RANGING PANORAMA OF SYSTEMIC AUTOINFLAMMATORY DISORDERS WITH SPECIFIC FOCUS ON ACUTE PAINFUL SYMPTOMS AND HEMATOLOGIC MANIFESTATIONS IN CHILDREN

    Donato Rigante
    e2018067
    2018-10-30
    https://doi.org/10.4084/mjhid.2018.067
    2114
    PDF: 1295
    HTML: 384
  • THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.

    Ugo Testa, Giuseppe Leone, Prof. M.D. Cappellini
    e2024068
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.068
    2183
    PDF: 1318
    Html: 302
  • SPECTRUM AND IMMUNOPHENOTYPIC PROFILE OF ACUTE LEUKEMIA: A TERTIARY CENTER FLOW CYTOMETRY EXPERIENCE

    Nishit Gupta, Ravikiran Pawar, Sambhunath Banerjee, Subhajit Brahma, Asish Rath, Sundar Shewale, Mayur Parihar, Manish Singh, Arun SR, Shekhar Krishnan, Arpita Bhattacharyya, Anirban Das, Jeevan Kumar, Saurabh Bhave, Vivek Radhakrishnan, Reena nair, Mammen Chandy, Neeraj Arora, Deepak Kumar Mishra
    e2019017
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.017
    3268
    PDF: 1638
    HTML: 440
  • EBV IN HODGKIN LYMPHOMA

    Giuseppina Massini, Doerte Siemer, Stefan Hohaus
    e2009013
    https://doi.org/10.4084/mjhid.2009.013
    1672
    PDF: 606
    HTML: 13958
  • MPN/MDS OVERLAP SYNDROME ANTICIPATED BY A SEVERE BLEEDING DIATHESIS: HYPOTHESIS OF A PRE-EXISTING PLATELET DISORDER

    Paola Ranalli, Stefano Baldoni, Daniela Bruno, Mauro Di Ianni
    e2024067
    2024-08-31
    https://doi.org/10.4084/MJHID.2024.067
    1127
    PDF: 648
    Html: 174
  • IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS

    Efterpi Kostareli, Maria Gounari, Andreas Agathangelidis, Kostas Stamatopoulos
    e2012052
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.052
    3094
    PDF: 884
    HTML: 7172
    Kost Fig1: 191
    Kost Fig 2: 184
    Kost Fig3: 182
    Kost Fig 4: 196
    Kost Fig5: 192
    Kost fig 6: 178
  • THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association

    Katia Paciaroni, Selenia Campagna, Nicoletta Villiva', Enrico Maffini, Francesca Celesti, Attilio Tordi, Mariangela Lombardi, Giulia Dragonetti, Tommaso Caravita di Toritto
    e2025023
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.023
    1086
    PDF: 1169
    HTML: 98
  • PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma

    Ugo Testa; Giuseppe G.M. Leone
    e2025005
    2024-12-31
    https://doi.org/10.4084/MJHID.2025.005
    2488
    HTML: 281
    PDF: 889
  • RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA

    Elahe Bordbar, Mehdi Taghipour, Beth E Zucconi
    e2015022
    2015-02-13
    https://doi.org/10.4084/mjhid.2015.022
    2057
    PDF: 1644
    HTML: 14651
    Untitled: 215
    Untitled: 181
  • TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH SINGLE-AGENT ARSENIC TRIOXIDE

    Vikram Mathews, Ezhilarasi Chendamarai, Biju George, Auro Viswabandya, Alok Srivastava
    e2011056
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.056
    3676
    PDF: 943
    HTML: 4470
  • Primary Pancreatic Lymphoma in a Patient with Maturity Onset Diabetes of the Young type 3

    Valentina Bozzoli, Maria Chiara Tisi, Luigi Pianese, Stefano Tumini, Vittoria Rufini, Maria Lucia Calcagni, Dario Pitocco, Alberto Larghi, Luigi Maria Larocca, Giuseppina Massini, Luciana Teofili, Francesco D'Alò, Stefan Hohaus
    e2012005
    2012-01-18
    https://doi.org/10.4084/mjhid.2012.005
    1545
    PDF: 718
    HTML: 979
  • ROLE OF STEM CELL FACTOR IN THE REACTIVATION OF HUMAN FETAL HEMOGLOBIN

    Marco Gabbianelli, Ugo Testa
    e2009009
    2009-11-12
    1153
    PDF: 481
    HTML: 4493
51 - 100 of 343 items << < 1 2 3 4 5 6 7 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.